S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Tivity Health Stock Forecast, Price & News

-0.14 (-0.58%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
181,062 shs
Average Volume
267,219 shs
Market Capitalization
$1.20 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for Tivity Health and its competitors with MarketBeat's FREE daily newsletter.

Tivity Health logo

About Tivity Health

Tivity Health, Inc. provides fitness, nutrition, and social connection solutions. It operates through two segments: Healthcare and Nutrition. The Healthcare segment consists of SilverSneakers senior fitness, Prime Fitness and WholeHealth Living. The Nutrition segment provides weight management products and services and consists of Nutrisystem and South Beach Diet. The company was founded by Robert E. Stone and Thomas G. Cigarran in 1981 and is headquartered in Franklin, TN.


See More Headlines

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Health Care Services
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$437.71 million
Cash Flow
$2.68 per share
Book Value
$0.08 per share


Net Income
$-223.63 million
Pretax Margin




Free Float
Market Cap
$1.20 billion

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.13 out of 5 stars

Medical Sector

494th out of 1,418 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

11th out of 22 stocks

Analyst Opinion: 2.2Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

Is Tivity Health a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Tivity Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TVTY, but not buy additional shares or sell existing shares.
View analyst ratings for Tivity Health
or view top-rated stocks.

How has Tivity Health's stock been impacted by COVID-19?

Tivity Health's stock was trading at $7.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TVTY shares have increased by 204.9% and is now trading at $24.09.
View which stocks have been most impacted by COVID-19

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Tivity Health

How were Tivity Health's earnings last quarter?

Tivity Health, Inc. (NASDAQ:TVTY) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.42 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.36 by $0.06. The business earned $126.29 million during the quarter, compared to analysts' expectations of $122.39 million. Tivity Health had a net margin of 26.07% and a trailing twelve-month return on equity of 163.79%. During the same period in the prior year, the company posted $0.72 EPS.
View Tivity Health's earnings history

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health updated its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided earnings per share (EPS) guidance of $1.610-$1.670 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.500. The company issued revenue guidance of $475 million-$485 million, compared to the consensus revenue estimate of $480.18 million.

What price target have analysts set for TVTY?

5 brokers have issued 12-month target prices for Tivity Health's shares. Their forecasts range from $25.00 to $33.00. On average, they expect Tivity Health's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 24.5% from the stock's current price.
View analysts' price targets for Tivity Health
or view top-rated stocks among Wall Street analysts.

Who are Tivity Health's key executives?

Tivity Health's management team includes the following people:
  • Richard M. Ashworth, President, Chief Executive Officer & Director
  • Tommy Lewis, Chief Operating Officer & President-Nutrition
  • Adam C. Holland, Chief Financial Officer
  • Sarah Richardson, Chief Information Officer
  • Paul Otto Wimer, Chief Experience & Strategy Officer

What is Richard Ashworth's approval rating as Tivity Health's CEO?

8 employees have rated Tivity Health CEO Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among Tivity Health's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tivity Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), (CGC), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Nordea Investment Management AB (0.14%), State of Alaska Department of Revenue (0.06%) and Pacifica Partners Inc. (0.00%). Company insiders that own Tivity Health stock include Anthony Michael Sanfilippo, Kevin Wills, Lee Shapiro and Sara Finley.
View institutional ownership trends for Tivity Health

Which institutional investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Nordea Investment Management AB, and Pacifica Partners Inc..
View insider buying and selling activity for Tivity Health
or view top insider-selling stocks.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $24.09.

How much money does Tivity Health make?

Tivity Health has a market capitalization of $1.20 billion and generates $437.71 million in revenue each year. The company earns $-223.63 million in net income (profit) each year or $2.36 on an earnings per share basis.

How many employees does Tivity Health have?

Tivity Health employs 1,000 workers across the globe.

When was Tivity Health founded?

Tivity Health was founded in 2017.

What is Tivity Health's official website?

The official website for Tivity Health is www.tivityhealth.com.

Where are Tivity Health's headquarters?

Tivity Health is headquartered at 701 Cool Springs Boulevard, Franklin TN, 37067.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at (800) 869-5311, via email at [email protected], or via fax at 302-674-5266.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.